Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Arthrofen 600 tablets
1001010J0B1AFAF
|
Arthrofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin 250 tablets
1001010P0BDACAD
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin 500 tablets
1001010P0BDADAE
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin EC 250 tablets
1001010P0BDAFAH
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin EC 500 tablets
1001010P0BDAEAI
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrum H 40mg/2ml injection pre-filled syringes
21012000160
|
Arthrum H 40mg/2ml injection pre-filled syringes | Other Appliances | Appliances | No data available |
|
Artificial saliva spray
1203050A0AAABAB
|
Artificial saliva | Artificial saliva products | Ear, Nose and Oropharynx | No data available |
|
Arzip 250mg capsules
0802010M0BDAAAA
|
Arzip | Mycophenolate mofetil | Malignant Disease and Immunosuppression | No data available |
|
Arzip 500mg tablets
0802010M0BDABAB
|
Arzip | Mycophenolate mofetil | Malignant Disease and Immunosuppression | No data available |
|
AS Saliva Orthana spray (A S Pharma)
1203050A0BEAAAB
|
AS Saliva Orthana | Artificial saliva products | Ear, Nose and Oropharynx | No data available |
|
AS Saliva Orthana spray refill (A S Pharma)
1203050A0BEABAC
|
AS Saliva Orthana | Artificial saliva products | Ear, Nose and Oropharynx | No data available |
|
Asacol 1g/application foam enema
0105010B0BBAEAK
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Asacol 250mg suppositories
0105010B0BBADAG
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Asasantin Retard capsules
0209000V0BBAAAA
|
Asasantin | Dipyridamole and aspirin | Cardiovascular System | No data available |
|
Ascabiol Emulsion 25%
1310040C0BBAAAA
|
Ascabiol | Benzyl benzoate | Skin | No data available |
|
Ascensia Autodisc testing discs
0601060D0BMABA0
|
Ascensia (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Ascensia Glucodisc testing discs
0601060D0BMAAA0
|
Ascensia (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Ascorb Vitamin C 1000mg effervescent tablets
0906031C0CGAEAN
|
Ascorb | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 1.5g modified-release tablets
0906031C0AABYBY
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 10% eye drops preservative free
1104020AFAAAAAA
|
Ascorbic acid (Eye) | Ascorbic acid (Eye) | Eye | No data available |
|
Ascorbic acid 100mg chewable tablets
0906031C0AABNBN
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 100mg/5ml oral liquid
0906031C0AABDBD
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 120mg chewable tablets
0906031C0AABVBV
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 1g / Zinc citrate 10mg efferv tab sugar free
091000000AABKBK
|
Generic compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | No data available |
|
Ascorbic acid 1g chewable tablets
0906031C0AABWBW
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.